课题基金 / 基金详情

ACETYLTRANSFERASE INHIBITION AND SELECTIVITY

ACETYLTRANSFERASE INHIBITION AND SELECTIVITY
乙酰转移酶抑制和选择性
批准号:
6628944
负责人:
PHILIP A COLE
金额:
$23.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-02-01 至 2005-01-31

项目摘要

项目成果

PHILIP A COLE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (adapted from applicant's abstract): Acetyltransferases play important roles in such diverse processes as circadian rhythm and the regulation of gene expression. Serotonin N-acetyltransferase is responsible for the circadian pattern of melatonin production in the pineal gland of animals and people. Histone acetyltransferases are proposed to modulate the remodeling of chromatin by catalyzing acetylation of key lysine residues on histones. They are also thought to serve as catalysts for the acetylation of a variety of transcription factors. The principal goals of this proposal concern the design, synthesis, and evaluation of inhibitors of serotonin N-acetyltransferase, the melatonin rhythm enzyme, and the histone acetyltransferases (HATs) PCAF and p300. In addition, the principal investigator seeks to better define the key determinants for HAT substrate recognition which may lead to the discovery of new biological substrates. The principal investigator seeks to build on initial findings that bi-substrate analogs can lead to potent and selective inhibitors of these enzymes. He will examine a range of modifications to enhance binding affinity, selectivity, and cell permeability. Designed compounds will be tested in vitro, potent ones will be examined using X-ray crystal structure analysis with the appropriate enzyme where possible, and in vivo in a variety of different systems. HAT substrate selectivity will be evaluated using peptide and protein substrates, using classical approaches as well as combinatorial libraries. Inhibitors of serotonin N-acetyltransferase will be useful as tools to evaluate the role of pineal serotonin and melatonin in circadian physiology and potentially as lead compounds for mood and sleep disorders. Selective inhibitors of HAT enzymes may be useful in the treatment of cancer, HIV, and other diseases related to the dysregulation of gene expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemical Approaches to Understanding Reversible Lysine Modifications
  • 批准号:
    10621611
  • 项目类别:
  • 资助金额:
    $44.75万
  • 财政年份:
    2023
  • 负责人:
    PHILIP A COLE
  • 依托单位:
FASEB SRC on Reversible Acetylation in Health and Disease
Biochemistry of the lysine beta-hydroxybutyrylation pathway
  • 批准号:
    10210387
  • 项目类别:
  • 资助金额:
    $53.31万
  • 财政年份:
    2018
  • 负责人:
    PHILIP A COLE
  • 依托单位:
Mechanistic Studies of EGFR/ErbB Receptor Tyrosine Kinases
  • 批准号:
    8606747
  • 项目类别:
  • 资助金额:
    $30.78万
  • 财政年份:
    2012
  • 负责人:
    PHILIP A COLE
  • 依托单位:
海外基金